The Impact of the Oil Phase Selection on Physicochemical Properties, Long-Term Stability, In Vitro Performance and Injectability of Curcumin-Loaded PEGylated Nanoemulsions.

A nanotechnology-based approach to drug delivery presents one of the biggest trends in biomedical science that can provide increased active concentration, bioavailability, and safety compared to conventional drug-delivery systems. Nanoemulsions stand out amongst other nanocarriers for being biodegradable, biocompatible, and relatively easy to manufacture. For improved drug-delivery properties, longer circulation for the nanoemulsion droplets should be provided, to allow the active to reach the target site. One of the strategies used for this purpose is PEGylation. The aim of this research was assessing the impact of the oil phase selection, soybean or fish oil mixtures with medium chain triglycerides, on the physicochemical characteristics and injectability of curcumin-loaded PEGylated nanoemulsions. Electron paramagnetic resonance spectroscopy demonstrated the structural impact of the oil phase on the stabilizing layer of nanoemulsions, with a more pronounced stabilizing effect of curcumin observed in the fish oil nanoemulsion compared to the soybean oil one. The design of the experiment study, employed to simultaneously assess the impact of the oil phase, different PEGylated phospholipids and their concentrations, as well as the presence of curcumin, showed that not only the investigated factors alone, but also their interactions, had a significant influence on the critical quality attributes of the PEGylated nanoemulsions. Detailed physicochemical characterization of the NEs found all formulations were appropriate for parenteral administration and remained stable during two years of storage, with the preserved antioxidant activity demonstrated by DPPH and FRAP assays. In vitro release studies showed a more pronounced release of curcumin from the fish oil NEs compared to that from the soybean oil ones. The innovative in vitro injectability assessment, designed to mimic intravenous application, proved that all formulations tested in selected experimental setting could be employed in prospective in vivo studies. Overall, the current study shows the importance of oil phase selection when formulating PEGylated nanoemulsions.

Curcumin Loaded PEGylated Nanoemulsions Designed for Maintained Antioxidant Effects and Improved Bioavailability: A Pilot Study on Rats.

The current study describes the experimental design guided development of PEGylated nanoemulsions as parenteral delivery systems for curcumin, a powerful antioxidant, as well as the evaluation of their physicochemical characteristics and antioxidant activity during the two years of storage. Experimental design setup helped development of nanoemulsion templates with critical quality attributes in line with parenteral application route. Curcumin-loaded nanoemulsions showed mean droplet size about 105 nm, polydispersity index <0.15, zeta potential of -40 mV, and acceptable osmolality of about 550 mOsm/kg. After two years of storage at room temperature, all formulations remained stable. Moreover, antioxidant activity remained intact, as demonstrated by DPPH (IC50 values 0.078-0.075 mg/mL after two years) and FRAPS assays. In vitro release testing proved that PEGylated phospholipids slowed down the curcumin release from nanoemulsions. The nanoemulsion carrier has been proven safe by the MTT test conducted with MRC-5 cell line, and effective on LS cell line. Results from the pharmacokinetic pilot study implied the PEGylated nanoemulsions improved plasma residence of curcumin 20 min after intravenous administration, compared to the non-PEGylated nanoemulsion (two-fold higher) or curcumin solution (three-fold higher). Overall, conclusion suggests that developed PEGylated nanoemulsions present an acceptable delivery system for parenteral administration of curcumin, being effective in preserving its stability and antioxidant capacity at the level highly comparable to the initial findings.

'All-natural' anti-wrinkle emulsion serum with Acmella oleracea extract: A design of experiments (DoE) formulation approach, rheology and in vivo skin performance/efficacy evaluation.

OBJECTIVE: The growing consumers' preferences and concerns regarding healthy ageing, youthful skin appearance, environmental protection and sustainability have triggered an ever-increasing trend towards natural, eco-friendly and ethically sourced anti-ageing products. Accordingly, this paper describes design and evaluation of novel, safe, effective and high-quality emulsion serums, completely based on ingredients of natural origin, intended for improving facial fine lines and wrinkles. METHODS: Model formulations, stabilized by an innovative glycolipid mixed emulsifier (lauryl glucoside/myristyl glucoside/polyglyceryl-6 laurate) and containing Acmella oleracea extract as a model anti-ageing active, were prepared by cold process and fully assessed regarding their rheological behaviour (continuous rotational and oscillatory tests) and physical stability (dynamic-mechanical thermoanalysis - DMTA test). To study and optimize the simultaneous influence of varied formulation factors (emollients and emulsifier concentrations) on critical rheological attributes of the developed serums, a central composite design within 'design of experiments' approach was employed. The general skin performance - preliminary safety and anti-wrinkle efficacy of selected model serum, was evaluated in human volunteers, by employing several objective, non-invasive bioengineering techniques. RESULTS: Rheological characterization revealed favourable shear-thinning flow behaviour with yield point, and dominating elastic character (storage modulus G' > loss modulus G") in both amplitude and frequency sweeps, which together with relatively small structural change obtained in DMTA test indicated overall satisfying rheological and stability properties of formulated serums. From the established design space, and taking into account formulation cost and carbon footprint, promising model serum (desired/optimal apparent viscosity, yield point and loss factor, rather small and constant structural change), containing 15% of emollients and 1% of emulsifier, was chosen for in vivo evaluations. Screening of skin irritation effects revealed the absence of potential irritancy of investigated serum, suggesting overall satisfying skin tolerability/preliminary safety. Silicone skin replica image analysis demonstrated noticeable reduction/improvement in all measured skin wrinkle parameters after only 2 weeks of test serum application in periorbital and perioral areas, indicating its rapid and beneficial effects on the facial expression lines and wrinkles. CONCLUSION: Altogether, the results corroborate the promising potential of the developed Acmella oleracea extract-loaded emulsion serum as safe, effective and non-invasive natural anti-wrinkle product.

OBJECTIF: Les préférences et les préoccupations croissantes des consommateurs concernant le vieillissement sain, l'apparence jeune de la peau, la protection de l'environnement et la durabilité ont déclenché une tendance toujours croissante vers des produits anti-âge naturels, respectueux de l'environnement et éthiques. En conséquence, ce document décrit le plan et l'évaluation de nouveaux sérums d'émulsion sûrs, efficaces et de haute qualité, entièrement basés sur des ingrédients d'origine naturelle, destinés à améliorer les ridules et rides du visage. MÉTHODES: Des formulations modèles stabilisées par un émulsifiant mixte glycolipide innovant (lauryl glucoside/myristyl glucoside/polyglycéryl-6 laurate) et contenant de l'extrait d'Acmella oleracea comme anti-vieillissement actif de modèle, ont été préparées par un procédé à froid et ont été pleinement évaluées en ce qui concerne leur comportement rhéologique (tests de rotation continue et examens oscillatoires) et stabilité physique (analyse thermomécanique dynamique - DMTA). Pour étudier et optimiser l'influence simultanée de facteurs de formulation variés (concentrations d'émollients et d'émulsifiants) sur les attributs rhéologiques critiques des sérums développés, une conception composite centrale dans le cadre d'une approche « conception d'expériences ¼ a été employée. Les performances cutanées générales - sécurité préliminaire et efficacité antirides du sérum du modèle sélectionné ont été évaluées chez des sujets humains volontaires, en utilisant plusieurs techniques de bio-ingénierie objectives et non invasives. RÉSULTATS: La caractérisation rhéologique a révélé un comportement favorable du débit de cisaillement avec une limite de rendement et une domination du caractère élastique (modulus de stockage G' > module de perte G) dans les balayages d'amplitude et de fréquence, qui, avec un changement structurel relativement faible obtenu dans l'analyse DMTA, a indiqué des propriétés rhéologiques et de stabilité satisfaisante globales des sérums. A partir de l'espace de conception établi, et en tenant compte du coût de composition et de l'empreinte carbone, un sérum modèle prometteur (viscosité apparente souhaitée/optimale, seuil de rendement et facteur de perte, changement structurel assez faible et constant), contenant 15 % d'émollients et 1 % d'émulsifiant, a été choisi pour les évaluations in vivo. Le dépistage des effets d'irritation cutanée a révélé l'absence d'irritation potentielle du sérum expérimental, suggérant une tolérance cutanée/une sécurité préliminaire globalement satisfaisante. L'analyse de l'image de la réplique cutanée en silicone a démontré une réduction/amélioration notable de tous les paramètres de rides cutanées mesurés après seulement deux semaines d'application du sérum test dans les zones périorbitaires et péribuccales, indiquant ses effets rapides et bénéfiques sur les lignes d'expression et les rides du visage. CONCLUSION: Au total, les résultats corroborent le potentiel prometteur du sérum d'émulsion à base d'extrait d'Acmella oleracea développé comme un produit anti-rides naturel sûr, efficace et non invasif.

Dynamic-mechanical thermoanalysis test as a high-performance alternative for accelerated freeze-thaw stability testing: a case study of O/W emulsions.

Objective: The main objective of this work was to evaluate the performance of recently developed dynamic-mechanical thermoanalysis (DMTA) test as a rapid rheological alternative to conventional freeze-thaw cycling for accelerated stability testing of oil-in-water (O/W) emulsions.Significance: The rational for this approach was reducing the time needed for product and process development and optimization, potentially through shortening the time needed for stability evaluation, in order to keep the pace with high formulating turnover imposed by increasing demands for placing products on the market, that is, to facilitate decision making in R&D and QC settings.Methods: Six model O/W emulsions were designed, rheologically characterized (continuous rotational and oscillatory tests), and subjected to stability evaluation through freeze-thaw test in stability chamber and DMTA tests using an air-bearing rheometer.Results: Investigated samples were characterized by favorized shear-thinning flow behavior with yield point. The elastic behavior dominated the viscous one in the LVE region of amplitude sweeps, as well as in the frequency sweeps of used frequency range. Statistical method comparison studies demonstrated that the results obtained by freeze-thaw test, routinely used for accelerated stability testing of emulsions, were in good accordance with those obtained with DMTA tests, whereas the time needed for stability assessment was significantly reduced (2-6 h versus 12 days).Conclusions: In summary, DMTA test proved to be an expeditious alternative for accelerated freeze-thaw stability testing of O/W emulsions, with great promise in new product development and optimization (R&D), as well as in determination of borderline product batches status (QC).

Dynamic-mechanical thermoanalysis test: a rapid alternative for accelerated freeze-thaw stability evaluation of W/O emulsions.

Objective: The aim of this study was to develop a new dynamic-mechanical thermoanalysis (DMTA) test and evaluate its performance as rapid rheological alternative to routinely used freeze-thaw test for accelerated stability testing of water-in-oil (W/O) emulsions.Significance: Due to inherent emulsion instability and versatilities of storage and use conditions, stability assessment of emulsion products still remains complex and challenging task. Recommended stability evaluation protocols are time-consuming, imposing need for alternate test procedures, especially in the early stage of product development, as well as in the quality assurance setting, including quality control.Methods: Five model W/O emulsions were prepared, comprehensively rheologically characterized (continual and oscillatory tests), and subjected to stability evaluation through freeze-thaw test in stability chamber and DMTA tests using an air-bearing rheometer.Results: Analyzed emulsions displayed desired shear-thinning flow behavior with yield point. The storage modulus dominated over the loss modulus in the linear viscoelastic regions of amplitude sweeps, as was the case in frequency sweeps over entire frequency range. Statistical comparison showed good agreement between freeze-thaw test, as a method available and used in daily routine work for accelerated evaluation of the physical stability, and DMTA test, as a rheological simulation of the said routine method. Duration of DMTA test was significantly shorter compared to routine but lengthy freeze-thaw test (3.5 h versus 12 days).Conclusions: According to our results, DMTA test could be a rapid alternative for accelerated freeze-thaw stability evaluation of W/O emulsions, thus enabling high formulating turnover and decision making in R&D and QC departments.

Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.

This work aimed to deepen the lately acquired knowledge about parenteral nanoemulsions as carriers for brain delivery of risperidone, a poorly water-soluble antipsychotic drug, through establishing the prospective relationship between their physicochemical, pharmacokinetic, biodistribution, and behavioral performances. For this purpose, two optimized risperidone-loaded nanoemulsions, stabilized by lecithin or lecithin/polysorbate 80 mixture, and costabilized by sodium oleate, were produced by high-pressure homogenization. The characterization revealed the favorable droplet size, narrow size distribution, high surface charge, with proven stability to autoclaving and long-term stability for at least one year at 25±2°C. Pharmacokinetic and tissue distribution results demonstrated improved plasma, liver, and brain pharmacokinetic parameters, resulting in 1.2-1.5-fold increased relative bioavailability, 1.1-1.8-fold decreased liver distribution, and about 1.3-fold improved brain uptake of risperidone active moiety following intraperitoneal administration of nanoemulsions relative to solution in rats. In behavioral study, investigated nanoemulsions showed pronounced reduction in basal and, more pertinently, amphetamine-induced locomotor activity in rats, with an early onset of antipsychotic action, and this effect lasted at least 90min after drug injection. Together, these findings corroborate the applicability of parenteral nanoemulsions as carriers for enhanced brain delivery of risperidone, further suggesting their promise in acute psychosis treatment or other emergency situations.

Alkyl polyglucoside vs. ethoxylated surfactant-based microemulsions as vehicles for two poorly water-soluble drugs: physicochemical characterization and in vivo skin performance.

Two types of biocompatible surfactants were evaluated for their capability to formulate skin-friendly/non-irritant microemulsions as vehicles for two poorly water-soluble model drugs differing in properties and concentrations: alkyl polyglucosides (decyl glucoside and caprylyl/capryl glucoside) and ethoxylated surfactants (glycereth-7-caprylate/ caprate and polysorbate 80). Phase behavior, structural inversion and microemulsion solubilization potential for sertaconazole nitrate and adapalene were found to be highly dependent on the surfactants structure and HLB value. Performed characterization (polarized light microscopy, pH, electrical conductivity, rheological, FTIR and DSC measurements) indicated a formulation containing glycereth- 7-caprylate/caprate as suitable for incorporation of both drugs, whereas alkyl polyglucoside-based systems did not exhibit satisfying solubilization capacity for sertaconazole nitrate. Further, monitored parameters were strongly affected by sertaconazole nitrate incorporation, while they remained almost unchanged in adapalene-loaded vehicles. In addition, results of the in vivo skin performance study supported acceptable tolerability for all investigated formulations, suggesting selected microemulsions as promising carriers worth exploring further for effective skin delivery of model drugs.

Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.

This paper describes design and evaluation of parenteral lecithin-based nanoemulsions intended for brain delivery of risperidone, a poorly water-soluble psychopharmacological drug. The nanoemulsions were prepared through cold/hot high pressure homogenization and characterized regarding droplet size, polydispersity, surface charge, morphology, drug-vehicle interactions, and physical stability. To estimate the simultaneous influence of nanoemulsion formulation and preparation parameters--co-emulsifier type, aqueous phase type, homogenization temperature--on the critical quality attributes of developed nanoemulsions, a general factorial experimental design was applied. From the established design space and stability data, promising risperidone-loaded nanoemulsions (mean size about 160 nm, size distribution <0.15, zeta potential around -50 mV), containing sodium oleate in the aqueous phase and polysorbate 80, poloxamer 188 or Solutol(®) HS15 as co-emulsifier, were produced by hot homogenization and their ability to improve risperidone delivery to the brain was assessed in rats. Pharmacokinetic study demonstrated erratic brain profiles of risperidone following intraperitoneal administration in selected nanoemulsions, most probably due to their different droplet surface properties (different composition of the stabilizing layer). Namely, polysorbate 80-costabilized nanoemulsion showed increased (1.4-7.4-fold higher) risperidone brain availability compared to other nanoemulsions and drug solution, suggesting this nanoemulsion as a promising carrier worth exploring further for brain targeting.

Experimental design in formulation of diazepam nanoemulsions: physicochemical and pharmacokinetic performances.

With the aid of experimental design, we developed and characterized nanoemulsions for parenteral drug delivery. Formulations containing a mixture of medium-chain triglycerides and soybean oil as oil phase, lecithin (soybean/egg) and polysorbate 80 as emulsifiers, and 0.1 M phosphate buffer solution (pH 8) as aqueous phase were prepared by cold high-pressure homogenization. To study the effects of the oil content, lecithin type, and the presence of diazepam as a model drug and their interactions on physicochemical characteristics of nanoemulsions, a three factor two-level full factorial design was applied. The nanoemulsions were evaluated concerning droplet size and size distribution, surface charge, viscosity, morphology, drug-excipient interactions, and physical stability. The characterization revealed the small spherical droplets in the range 195 -220 nm with polydispersity index below 0.15 and zeta potential between -30 and - 60 mV. Interactions among the investigated factors, rather than factors alone, were shown to more profoundly affect nanoemulsion characteristics. In vivo pharmacokinetic study of selected diazepam nanoemulsions with different oil content (20%, 30%, and 40%, w/w) demonstrated fast and intense initial distribution into rat brain of diazepam from nanoemulsions with 20% and 30% (w/w) oil content, suggesting their applicability in urgent situations.

Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles.

BACKGROUND: The potential for use of chitosan-treated alginate microparticles as a vehicle for oral phenytoin delivery has not been thoroughly exploited. AIM: We studied the influence of preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles. METHOD: The total number of 24 microparticles formulations prepared by varying contents of calcium gelling ions and varying contents and type of chitosan was examined. As an additional variable, two different hardening times (1 and 24 hours) were employed. Possible interactions of components, surface morphology of microparticles as well as release profile of phenytoin were studied. RESULTS: Both series of formulations with regard to hardening times, irrespective of the chitosan type and/or concentration employed appeared to be highly loaded with the model drug (above 90%). The drug release studies showed that the kinetics of phenytoin cannot be straightforwardly predicted based on the molecular weight of chitosan alone. On the other hand, prolonging the hardening time from 1 to 24 hours had significantly improved phenytoin kinetics, and gave rise to a formulation with the liberation half-time of about 2.5 hours. CONCLUSION: This study showed that the latter formulation is eligible for further modifications aimed at improving the regularity of phenytoin absorption.

Preparation and characterisation of phenytoin-loaded alginate and alginate-chitosan microparticles.

We aimed to prepare and investigate microparticles with the varying contents of calcium gelling ion, loaded with phenytoin, a standard antiepileptic agent, in its acidic form. Two different methods of alginate-based microparticles preparation were used: with and without treatment with chitosan. Furthermore, two standard procedures, the one-stage and the two-stage, were applied. Microparticle size of 12 one-stage formulations ranged from 466 to 636 mum. Both types of formulations, chitosan-treated and nontreated, appeared to be highly loaded with the model drug (91-96%). The chitosan-coated alginate-based microparticles prepared by the one-stage procedure exhibited kinetics of phenytoin liberation comparable to a similar sustained release system that had been tested at pH 6.8, as published earlier. As the gel erosion of alginate-based microparticles should be potentiated by the higher pH (used in the present study at pH 7.4), the most favorable of 12 formulations, with the liberation half-time of about 2 hr, seemed to be eligible for further modifications. Counterintuitively, the applied two-stage procedure did not appear to beneficially affect the dissolution behavior of phenytoin when tested in two formulations, which makes further modifications necessary.